Press Release

Monday, 18 December 2017

Gene therapy for rare blood condition

Scientists at Hannover Medical School (MHH) have achieved a first: they have developed a successful cell and gene therapy for a genetic infectious disease. It appears to be a promising treatment for a rare and life-threatening condition called ‘Mendelian susceptibility to mycobacterial disease’ (MSMD), in that it protects sufferers from mycobacterial pathogens. The researchers published their findings in Blood, the prestigious journal of the American Society for Hematology (ASH).

Download the press release (in German):
171218_Lachmann.pdf